Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 28, 2015
Patent Application Number
14180137
Date Filed
February 13, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are methods for treating bleeding disorders, such as hemophilia, in subjects in need thereof by administering an antibody that specifically binds CD73. The methods reduce production of adenosine, increase platelet activation and/or enhance the level of coagulation on the platelet surface to reduce and/or stop bleeding. In some embodiments, the methods can further include co-administering Factor VIII to treat the bleeding disorder.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.